Stay updated on Daratumumab Combo in MRD+ Myeloma Clinical Trial

Sign up to get notified when there's something new on the Daratumumab Combo in MRD+ Myeloma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Daratumumab Combo in MRD+ Myeloma Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    Added related topic 'Multiple myeloma' and a link to MedlinePlus Genetics. Updated page revision from v3.4.3 to v3.5.0.
    Difference
    0.1%
    Check dated 2026-03-25T20:47:41.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    Administrative date updates were added to the study record, reflecting recent edits and posting times but not altering the study details.
    Difference
    0.2%
    Check dated 2026-03-18T13:58:33.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    Page revision updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-11T06:34:34.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    Added related topics metadata: Multiple myeloma and MedlinePlus Genetics. This metadata helps with navigation and discovery without changing the study content.
    Difference
    0.1%
    Check dated 2026-03-04T02:23:55.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    Added new trial sites in Detroit (Henry Ford Cancer - Detroit Brigitte Harris Cancer Pavilion), Novant Health, and Temple University Hospital Jeanes Campus. Removed existing sites including Fox Chase Cancer Center and Henry Ford Cancer Institute.
    Difference
    0.4%
    Check dated 2026-02-17T16:24:24.000Z thumbnail image
  7. Check
    55 days ago
    Change Detected
    Summary
    Added related topic links for Multiple Myeloma and MedlinePlus Genetics and updated the page revision to v3.4.1; a government funding notice was removed. The study data, endpoints, and eligibility criteria remain unchanged.
    Difference
    0.3%
    Check dated 2026-02-10T07:52:02.000Z thumbnail image

Stay in the know with updates to Daratumumab Combo in MRD+ Myeloma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Daratumumab Combo in MRD+ Myeloma Clinical Trial page.